RACHEL SWART, M.D.,PH.D
Hematology & Oncology Physician · TUCSON, AZ
Individual Active NPI 1801097266
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 802 | 192,926 | $15,699,379 | $4,306,461 | $3,426,351 |
| 2023 | 671 | 149,423 | $9,767,232 | $2,577,843 | $2,048,184 |
| 2022 | 623 | 125,754 | $8,184,911 | $2,254,682 | $1,801,914 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,770 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 12,808 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,380 | $56 | $45 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,080 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 9,462 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,516 | $3 | $2 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 8,100 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 8,100 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,040 | $25 | $20 |
| J9171 | Injection, docetaxel, 1 mg | 4,036 | $1 | $1 |
| J0185 | Injection, aprepitant, 1 mg | 3,640 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,798 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 36169 | AZ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Arizona
- NPI 1497070221
- NPI 1477817971
- NPI 1730341850
- NPI 1306285267
- NPI 1144392291
- NPI 1093370918
- NPI 1679501282
- NPI 1578976379
See all Hematology & Oncology Physician providers in Arizona →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.